Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Haeften, G. Bolli, G. Dimitriadis, I. Gottesman, D. Horwitz, J. Gerich (1986)
Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus.Metabolism: clinical and experimental, 35 7
P. Reichard, B. Berglund, A. Britz, I. Cars, B. Nilsson, U. Rosenqvist (1991)
Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yearsJournal of Internal Medicine, 230
C. Christensen, J. Christiansen, A. Schmitz, T. Christensen, K. Hermansen, C. Mogensen (1987)
Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study.The Journal of diabetic complications, 1 3
PingH. Wang, Joseph Lau, T. Chalmers (1993)
Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetesThe Lancet, 341
B. Linde, R. Gunnarsson (1985)
Influence of aprotinin on insulin absorption and subcutaneous blood flow in Type 1 (insulin-dependent) diabetesDiabetologia, 28
D. Owens (1986)
Clinical-Pharmacological Studies
Steven Kang, J. Brange, A. Burch, A. Vølund, D. Owens (1991)
Subcutaneous Insulin Absorption Explained by Insulin's Physicochemical Properties: Evidence From Absorption Studies of Soluble Human Insulin and Insulin Analogues in HumansDiabetes Care, 14
T. Olsen, N. Ehlers, B. Richelsen, H. Beck-Nielsen (1987)
Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII)Acta Ophthalmologica, 65
A. Verrillo, A. Teresa, C. Martino, L. Verrillo, G. Chiara (1988)
Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.Diabetes research, 8 2
B. Linde (1986)
Dissociation of Insulin Absorption and Blood Flow During Massage of a Subcutaneous Injection SiteDiabetes Care, 9
Lutz Heinemann, A. Starke, L. Heding, I. Jensen, Michael Berger (1990)
Action profiles of fast onset insulin analoguesDiabetologia, 33
Diabetes Control, D. Nathan, S. Genuth, J. Lachin, P. Cleary, O. Crofford, M. Davis, L. Rand, C. Siebert (1993)
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes MellitusSurvey of Anesthesiology, 38
Steven Kang, F. Creagh, J. Peters, J. Brange, A. Vølund, D. Owens (1991)
Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic SubjectsDiabetes Care, 14
D. Goldstein, S. Peth, J. England, R. Hess, Jose Costa (1980)
Effects of Acute Changes in Blood Glucose on HbA1cDiabetes, 29
E. Eschwège, D. Job, C. Guyot-Argenton, J. Aubry, G. Tchobroutsky (2004)
Delayed progression of diabetic retinopathy by divided insulin administration: A further follow-upDiabetologia, 16
O. Hother-Nielsen, O. Faber, N. Sørensen, H. Beck-Nielsen (1988)
Classification of Newly Diagnosed Diabetic Patients as Insulin-Requiring or Non—Insulin-Requiring Based on Clinical and Biochemical VariablesDiabetes Care, 11
J. Schlichtkrull, O. Munck, M. Jersild (1964)
[M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS].Ugeskrift for laeger, 126
M. Gall, E. Mathiesen, P. Skøtt, L. Musaeus, S. Damm, H. Beck-Nielsen, H. Parving (1989)
Effect of multiple insulin injections with a pen injector on metabolic control and general well-being in insulin-dependent diabetes mellitus.Diabetes research, 11 2
C. Houtzagers, P. Berntzen, H. Stap, W. Maarschalkerweerd, P. Lanting, I. Boen-Tan, Robert Heine, E. Veen (1989)
Efficacy and Acceptance of Two Intensified Conventional Insulin Therapy Regimens: a Long‐term Cross‐over ComparisonDiabetic Medicine, 6
P. Home, J. Pickup, H. Keen, K. Alberti, J. Parsons, C. Binder (1981)
Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose.Metabolism: clinical and experimental, 30 5
L. Heding (1972)
Determination of total serum insulin (IRI) in insulin-treated diabetic patientsDiabetologia, 8
B. Edsberg, D. Herly, P. Hildebrandt, C. Kühl (1987)
Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.British Medical Journal (Clinical research ed.), 294
H. Beck-Nielsen, Bjørn Richelsen, C. Mogensen, Thomas Olsen, Niels Ehlers, Carsten Nielsen, P. Charles (1985)
Effect of Insulin Pump Treatment for One Year on Renal Function and Retinal Morphology in Patients with IDDMDiabetes Care, 8
R. Dillon (1983)
Improved Serum Insulin Profiles in Diabetic Individuals Who Massaged Their Insulin Injection SitesDiabetes Care, 6
T. Blundell, G. Dodson, D. Hodgkin, D. Mercola (1972)
Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology byAdvances in Protein Chemistry, 26
C. Binder (2009)
Absorption of injected insulin. A clinical-pharmacological study.Acta pharmacologica et toxicologica, 27 Suppl 2
E. Mosekilde, K. Jensen, C. Binder, S. Pramming, B. Thorsteinsson (1989)
Modeling absorption kinetics of subcutaneous injected soluble insulinJournal of Pharmacokinetics and Biopharmaceutics, 17
M. Small, S. MacRury, A. Boal, K. Paterson, A. Maccuish (1988)
Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.Diabetes research, 8 2
Kroccollaborativestudygroup (1984)
Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial.The New England journal of medicine, 311 6
Karin Bornfeldt, R. Gidlöf, Å. Wasteson, M. Lake, A. Skottner, Hans Arnqvist (1991)
Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activitiesDiabetologia, 34
W. Friedewald, R. Levy, D. Fredrickson (1972)
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clinical chemistry, 18 6
R. Eaton, R. Allen, D. Schade, J. Standefer (1980)
“Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?Diabetes Care, 3
P. Jansson, J. Fowelin, Henning Schenck, U. Smith, P. Lönnroth (1993)
Measurement by Microdialysis of the Insulin Concentration in Subcutaneous Interstitial Fluid: Importance of the Endothelial Barrier for InsulinDiabetes, 42
A. Tiengo, T. Segato, G. Briani, Antonio Setti, S. Prato, A. Devide, D. Padovan, F. Virgili, G. Crepaldi (1983)
The Presence of Retinopathy in Patients with Secondary Diabetes Following Pancreatectomy or Chronic PancreatitisDiabetes Care, 6
R. Taylor, P. Home, K. Alberti (1981)
Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe InjectionDiabetes Care, 4
(1990)
Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen. A questionnaire study
D. Schade, R. Eaton, W. Spencer (1980)
Normalization of Plasma Insulin Profiles in Diabetic Subjects with Programmed Insulin DeliveryDiabetes Care, 3
D. Owens (1986)
Human Insulin
Steven Kang, J. Brange, A. Burch, A. Vølund, D. Owens (1991)
Absorption Kinetics and Action Profiles of Subcutaneously Administered Insulin Analogues (AspB9GluB27, AspB10, AspB28) in Healthy SubjectsDiabetes Care, 14
J. Brange, U. Ribel, J. Hansen, G. Dodson, M. Hansen, S. Havelund, S. Melberg, F. Norris, K. Norris, L. Snel, A. Sorensen, H. Voigt (1988)
Monomeric insulins obtained by protein engineering and their medical implicationsNature, 333
G. Pehling, J. Gerich (1984)
Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitus.Mayo Clinic proceedings, 59 11
K. Dahl-Jørgensen, Kristian Hanssen, Peter Kierulf, Trine Bjøro, Leiv Sandvik, Ø. Aagenæs (1988)
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study.Acta endocrinologica, 117 1
I. Andersen, S. Hannibal (1983)
Analytical and economical optimization of a glucose method with immobilized enzymesThe Journal of Automatic Chemistry, 5
125 38 38 5 5 Dr. F. S. Nielsen L. N. JØrgensen M. Ipsen A. I. Voldsgaard H. -H. Parving Steno Diabetes Center Niels Steensens Vej 2 DK-2820 Gentofte Denmark Novo Nordisk A. S. BagsvÆrd Denmark Summary Recombinant DNA technology allows the production of insulin analogues with faster absorption rates from subcutaneous tissue as compared to soluble human insulin. The human insulin analogue B10Asp (mono/dimeric) is absorbed twice as fast as soluble human insulin (hexameric). A double blind, randomised crossover study with a 1-month run-in period and two 2-month treatment periods was performed in 21 male insulin-dependent diabetic (IDDM) patients aged 18–40 years in order to compare the metabolic control obtained with equimolar doses of the analogue B10Asp vs soluble human insulin (Actrapid) given as mealtime insulin and intermediate acting isophane insulin (Protaphane) at bedtime. At the end of each 2-month study period, the patients were admitted to the metabolic ward. We found significantly higher plasma insulin/analogue levels after breakfast, lunch and dinner with B10Asp as compared to Actrapid ( p <0.05). The plasma insulin/analogue levels were significantly lower before lunch and dinner with B10Asp as compared to Actrapid ( p <0.05). Also, the plasma insulin/analogue level tended to be lower at bedtime when comparing B10Asp to Actrapid. The 24-h blood glucose profiles showed identical fasting blood glucose, significantly lower blood glucose after breakfast with the analogue ( p <0.05), no differences in blood glucose after lunch and dinner but a significantly higher blood glucose at midnight using the analogue ( p <0.05). The overall 24-h mean blood glucose concentrations, the daily insulin dose, HbA 1c , diet, home blood glucose monitoring and frequency of hypoglycaemia were almost identical in the two treatment periods. In conclusion, the overall glycaemic control remained unchanged and quite good when Actrapid was exchanged dose for dose with the insulin analogue B10Asp in IDDM patients treated with a basal bolus regime.
Diabetologia – Springer Journals
Published: May 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.